Company intelligence / Profile preview

Epitope Diagnostics

San Diego, California, United Statesepitopediagnostics.com ↗

Ownership: Private
Employees: ~17
Development stage: Commercial

Overview

Epitope Diagnostics has developed and commercialized a broad portfolio of in-vitro diagnostic products including ELISA kits for proteins and antibodies relevant to cancer research, infectious disease diagnosis, autoimmune disorders and metabolic conditions. The company holds patents for several innovative test devices and was first to market with certain specialty assays such as human Fetuin A ELISA Kit and HAHA ELISA kit. Their products are ISO13485 certified and FDA registered for clinical use in professional laboratories globally.

Therapeutic areas: OncologyEndocrinologyImmunologyHematologyGastroenterologyCardiovascularInfectious Diseases
Modalities: AntibodyMonoclonal antibodyProteinDevice
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Epitope Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epitope Diagnostics.

Explore the full profile